NASDAQ:ELOX
Eloxx Pharmaceuticals Inc. Stock News
$0.80
+0.0430 (+5.68%)
At Close: May 30, 2024
Hemogenyx Pharmaceuticals PLC Announces Appointment of Business Advisor & Board Observer
02:00am, Monday, 26'th Jul 2021
Dr Alan E. Walts joins Hemogenyx Pharmaceuticals team; renowned business leader brings industry experience in corporate and private venture capital, business development, R&D and general management. L
Eloxx Pharmaceuticals Provides Enrollment Update for Ongoing Phase 2 Clinical Studies for Cystic Fibrosis
04:15pm, Tuesday, 06'th Jul 2021
Data Readout for First Four Treatment Arms Expected in the Fourth Quarter of 2021 Data Readout for First Four Treatment Arms Expected in the Fourth Quarter of 2021
7 Reddit Penny Stocks to Watch For the Long Weekend
09:09am, Thursday, 01'st Jul 2021
With July 4th on the way, which penny stocks are you watching right now? The post 7 Reddit Penny Stocks to Watch For the Long Weekend appeared first on Penny Stocks to Buy, Picks, News and Information
ELOX Stock Price Increases Over 7% Pre-Market: Why It Happened
05:58am, Tuesday, 15'th Jun 2021
The stock price of Eloxx Pharmaceuticals Inc (NASDAQ: ELOX) increased by over 7% pre-market. This is why it happened.
Are Options Traders Betting on a Big Move in Eloxx Pharmaceuticals (ELOX) Stock?
09:46am, Friday, 21'st May 2021
Investors need to pay close attention to Eloxx Pharmaceuticals (ELOX) stock based on the movements in the options market lately.
Is the Options Market Predicting a Spike in Eloxx (ELOX) Stock?
09:46am, Wednesday, 19'th May 2021
Investors need to pay close attention to Eloxx (ELOX) stock based on the movements in the options market lately.
WALTHAM, Mass., May 18, 2021 (GLOBE NEWSWIRE) -- Eloxx Pharmaceuticals, Inc. (the “Company”) (Nasdaq: ELOX), a leader in ribosomal RNA-targeted genetic therapies for rare diseases, today announced
Eloxx Pharmaceuticals Inc (NASDAQ: ELOX) Stock: Over 20% Decrease Explanation
02:16pm, Friday, 14'th May 2021
The stock price of Eloxx Pharmaceuticals Inc (NASDAQ: ELOX) decreased by over 20% during intraday trading. This is why it happened.
Eloxx Pharmaceuticals, Inc. Announces Pricing of Public Offering of Common Stock
07:00am, Friday, 14'th May 2021
WALTHAM, Mass., May 14, 2021 (GLOBE NEWSWIRE) -- Eloxx Pharmaceuticals, Inc. (the “Company”) (Nasdaq: ELOX), a leader in ribosomal RNA-targeted genetic therapies for rare diseases, today announced
Eloxx Pharmaceuticals Reports First Quarter 2021 Financial and Operating Results and Provides Business Update
05:15pm, Thursday, 06'th May 2021
Acquisition of Zikani Therapeutics, Ribosomal Modulation Company; Combined Company Advancing Ribosomal RNA-Targeted Genetic Therapies
Eloxx Pharmaceuticals (ELOX) Is in Oversold Territory: What's Next?
09:01am, Tuesday, 20'th Apr 2021
Eloxx Pharmaceuticals (ELOX) has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock.
Eloxx Pharmaceuticals Stock Price Increased Over 15% Pre-Market: Why It Happened
08:40am, Thursday, 01'st Apr 2021
The stock price of Eloxx Pharmaceuticals (NASDAQ: ELOX) increased by over 15% pre-market. This is why it happened.
Eloxx Pharmaceuticals Acquires Zikani Therapeutics
07:45am, Thursday, 01'st Apr 2021
Combined Company to be Leader in Ribosomal RNA-Targeted Genetic Therapy Bringing Together Complementary Platforms
Eloxx Pharmaceuticals, Inc. (ELOX) CEO Greg Williams on Q4 2020 Results - Earnings Call Transcript
08:56pm, Thursday, 11'th Mar 2021
Eloxx Pharmaceuticals, Inc. (ELOX) CEO Greg Williams on Q4 2020 Results - Earnings Call Transcript
Eloxx Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial and Operating Results and Provides Business Update
04:01pm, Thursday, 11'th Mar 2021
We expect to report top line data from our Phase 2 cystic fibrosis clinical trials in the first half of this year
